Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.

Cavaco-Silva J, Abecasis A, Miranda AC, Poças J, Narciso J, Águas MJ, Maltez F, Almeida I, Germano I, Diniz A, Gonçalves Mde F, Gomes P, Cunha C, Camacho RJ; Portuguese HIV-2 Resistance Study Group.

PLoS One. 2014 Mar 28;9(3):e92747. doi: 10.1371/journal.pone.0092747. eCollection 2014.

PMID:
24681625
[PubMed - in process]
Free PMC Article
2.

HIV-1 Genetic Variability and Clinical Implications.

Santoro MM, Perno CF.

ISRN Microbiol. 2013 Jun 17;2013:481314. doi: 10.1155/2013/481314. Print 2013.

PMID:
23844315
[PubMed]
Free PMC Article
3.

G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to raltegravir whereas Y143C does not.

Ni XJ, Delelis O, Charpentier C, Storto A, Collin G, Damond F, Descamps D, Mouscadet JF.

Retrovirology. 2011 Aug 19;8:68. doi: 10.1186/1742-4690-8-68.

PMID:
21854605
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa.

Gottlieb GS, Smith RA, Dia Badiane NM, Ba S, Hawes SE, Toure M, Starling AK, Traore F, Sall F, Cherne SL, Stern J, Wong KG, Lu P, Kim M, Raugi DN, Lam A, Mullins JI, Kiviat NB; Papa Salif Sow for the UW-Dakar HIV-2 Study Group.

PLoS One. 2011;6(7):e22204. doi: 10.1371/journal.pone.0022204. Epub 2011 Jul 12.

PMID:
21765953
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir.

Bercoff DP, Triqueneaux P, Lambert C, Oumar AA, Ternes AM, Dao S, Goubau P, Schmit JC, Ruelle J.

Retrovirology. 2010 Nov 29;7:98. doi: 10.1186/1742-4690-7-98.

PMID:
21114823
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.

Jallow S, Alabi A, Sarge-Njie R, Peterson K, Whittle H, Corrah T, Jaye A, Cotten M, Vanham G, McConkey SJ, Rowland-Jones S, Janssens W.

J Clin Microbiol. 2009 Jul;47(7):2200-8. doi: 10.1128/JCM.01654-08. Epub 2009 May 6.

PMID:
19420165
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa.

Gottlieb GS, Badiane NM, Hawes SE, Fortes L, Toure M, Ndour CT, Starling AK, Traore F, Sall F, Wong KG, Cherne SL, Anderson DJ, Dye SA, Smith RA, Mullins JI, Kiviat NB, Sow PS; University of Washington-Dakar HIV-2 Study Group.

Clin Infect Dis. 2009 Feb 15;48(4):476-83. doi: 10.1086/596504. Erratum in: Clin Infect Dis. 2009 Mar 15;48(6):848.

PMID:
19143530
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa.

Gottlieb GS, Eholié SP, Nkengasong JN, Jallow S, Rowland-Jones S, Whittle HC, Sow PS.

AIDS. 2008 Oct 18;22(16):2069-72; discussion 2073-4. doi: 10.1097/QAD.0b013e32830edd44. No abstract available.

PMID:
18832869
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Determinants of human immunodeficiency virus type 1 resistance to membrane-anchored gp41-derived peptides.

Lohrengel S, Hermann F, Hagmann I, Oberwinkler H, Scrivano L, Hoffmann C, von Laer D, Dittmar MT.

J Virol. 2005 Aug;79(16):10237-46.

PMID:
16051817
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk